Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma
Maintenance with capecitabine seems safe and may represent a valuable option in patients with advanced PC controlled using FOLFIRINOX or gemcitabine/nab-Paclitaxel induction treatment.
Authors
- Gayle Jameson (ORCID: https://orcid.org/0000-0003-0987-5965)
- Lana Caldwell
- Chase Irwin (ORCID: https://orcid.org/0000-0002-3165-0693)
- Erkut Borazanci (ORCID: https://orcid.org/0000-0001-5136-5462)
- Jordan Powell
- Alexa F. Viniotis (ORCID: https://orcid.org/0000-0002-8990-4684)
Institutions
- University of Arizona (US)
- HonorHealth (US)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251321894
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00